In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 48 for your search:
Cancer Type/Condition:  Brain tumor, adult: General and other
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00616, CALGB-A071102, A071102, U10CA180821, U10CA031946, NCT02152982

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N0577, NCI-2011-01915, EORTC-26081-22086, EudraCT-2008-007295-14, CDR0000640442, N0577, NCT00887146

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000654697, ECOG-E3F05, E3F05, NCT00978458

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906

5.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: OHSU-2868, P30CA069533, 8507, SOL-04058-L, 2868, OHSU-8507, OHSU-SOL-04058-L, NCT00303849

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110266, 11-C-0266, NCT01454596

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01989, CDR0000737109, NCCTG-N1174, N1174, U10CA180821, U10CA025224, NCT01648348

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: BRN0023, NCI-2013-02012, P30CA124435, NCT01977677

9.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: OHSU-922, ONC-02059-L, 922, 7328, OHSU-7328, OHSU-ONC-02059-L, CASE-CCF-6385, NCT00075387

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6803, NCI-2010-00714, P30CA015704, UWCC-6803, FHCRC-6803, IR-6803, NCCN-C01, NCT00823797

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N0872, NCI-2011-01921, CDR0000641746, N0872, NCT00892177

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCSF-081010, 081010, C-100-37, NCT00912951

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000657015, P30CA016042, UCLA-X05303, 09-03-084, MILLENNIUM-UCLA-X05303, X05303, NCT00998010

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 3 to 25
Sponsor: NCI, Other
Protocol IDs: 09-361, P01CA021239, NCT01063114

15.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10-218, NCT01199978

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10-439, NCT01358058

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01969, CDR0000734205, RTOG 1122, U10CA180868, U10CA021661, NCT01609790

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-1205, NCI-2012-01732, U10CA021661, NCT01730950

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CASE4312, NCI-2012-02284, NCT01753713

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03040, P121002, NCT01757652

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: A071101, U10CA031946, NCI-2013-00444, NCT01814813

22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 22 and over
Sponsor: NCI, Other
Protocol IDs: CASE3313, P30CA043703, NCT01894061

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 66
Sponsor: NCI
Protocol IDs: 130214, 13-C-0214, NCT01967823

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: DTI-022, R44CA125871-03, NCT02038218

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NRG-BN001, NCI-2014-01072, U10CA180868, NCT02163135
1   
New Search